J
Juan Palou Redorta
Researcher at Autonomous University of Barcelona
Publications - 27
Citations - 792
Juan Palou Redorta is an academic researcher from Autonomous University of Barcelona. The author has contributed to research in topics: Cystectomy & Bladder cancer. The author has an hindex of 10, co-authored 22 publications receiving 704 citations.
Papers
More filters
Journal ArticleDOI
Laparoscopic nephroureterectomy for upper urinary tract transitional cell carcinoma: is it better than open surgery?
Jens Rassweiler,Michael Schulze,Reinaldo Marrero,Thomas Frede,Juan Palou Redorta,Pierfrancesco Bassi +5 more
TL;DR: Open radical nephroureterectomy still represents the golden standard for the management of upper tract transitional cell carcinoma, however, laparoscopy offers the advantages of minimally invasive surgery without deteriorating the oncological outcome.
Journal ArticleDOI
EAU guidelines for the management of genitourinary tuberculosis.
Mete Cek,Severin Lenk,Kurt G. Naber,Michael C. Bishop,Truls E. Bjerklund Johansen,Henry Botto,Magnus Grabe,Bernard Lobel,Juan Palou Redorta,Peter Tenke +9 more
TL;DR: Although chemotherapy is the mainstay of treatment, surgery in the form of ablation or reconstruction may be unavoidable and both radical and reconstructive surgery should be carried out in the first 2 months of intensive chemotherapy.
Journal ArticleDOI
Hexaminolevulinate-guided fluorescence cystoscopy in the diagnosis and follow-up of patients with non-muscle-invasive bladder cancer: review of the evidence and recommendations.
J. Alfred Witjes,Juan Palou Redorta,Didier Jacqmin,Frank Sofras,Per-Uno Malmström,Claus Riedl,Dieter Jocham,Giario Conti,Francesco Montorsi,Harm C. Arentsen,Dirk Zaak,A. Hugh Mostafid,Marko Babjuk +12 more
TL;DR: Evidence is available to support the use of hexaminolevulinate-guided fluorescence cystoscopy in a range of indications, as endorsed by an expert panel.
Journal ArticleDOI
Clinical and cost effectiveness of hexaminolevulinate-guided blue-light cystoscopy: Evidence review and updated expert recommendations
J. Alfred Witjes,Marek Babjuk,Paolo Gontero,Didier Jacqmin,Alexander Karl,Stephan Kruck,Paramananthan Mariappan,Juan Palou Redorta,Arnulf Stenzl,Roland Van Velthoven,Dirk Zaak +10 more
TL;DR: HAL-guided BLC is a clinically effective and cost-effective tool for improving NMIBC detection and management, thereby reducing the burden of disease for patients and the health care system.
Journal ArticleDOI
EAU Guidelines for the Management of Urogenital Schistosomiasis
Karl Horst Bichler,Ilya Savatovsky,Kurt G. Naber,Michael C. Bischop,Truls E. Bjerklund-Johansen,Henry Botto,Mete Cek,Magnus Grabe,Bernhard Lobel,Juan Palou Redorta,Peter Tenke +10 more
TL;DR: More than 100 million people worldwide are affected by bilharziasis, caused by Schistosoma haematobium.